RADEK SKODA to Clinical Trials as Topic
This is a "connection" page, showing publications RADEK SKODA has written about Clinical Trials as Topic.
Connection Strength
0.014
-
BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features. Leukemia. 2008 Nov; 22(11):1975-89.
Score: 0.014
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.